Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05084859
Title A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Biosplice Therapeutics, Inc.
Indications

lung non-small cell carcinoma

colorectal cancer

prostate cancer

Therapies

Abiraterone + Prednisone + SM08502

Fluorouracil + Irinotecan + Leucovorin + Panitumumab + SM08502

Docetaxel + SM08502

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.